Skip to main content
. Author manuscript; available in PMC: 2014 Jan 27.
Published in final edited form as: Transplantation. 2013 Jan 27;95(2):389–396. doi: 10.1097/TP.0b013e318273878c

Table 1.

Baseline Demographic and Clinical Characteristics of the Patients

Variable DSA I+ (n=4) DSA II+ (n=11) DSA− (n=34)
Recipient age, years 56.7 [44.8, 69.7] 51.7 [47.9, 60.4] 55.3 [46.9, 61.5]
Gender—male, n(%) 3(75) 9(82) 26(76)
Time from transplant to 1st IVUS (years) 0.99 [0.36, 1.15] 0.20 [0.18, 1.05] 0.62 [0.18, 1.22]
Time between IVUS exams 1.00 [0.95, 1.05] 0.84 [0.76, 0.92] 0.96 [0.84, 1.06]
ICMP, n(%) 0(0)* 5(45) 7(21)
Donor age (years) 21.5 [20.0, 33.2] 21 [17.0, 29.0] 30.7 [22.1, 46.7]
Ischemic time (min) 161.5 [158.0, 173.4] 185 [160.0, 240.0] 183.0 [131.2, 210.7]
BMI (kg/m2) 22.8 [20.4, 24.0] 27.3 [21.6, 31.9] 26.0 [22.2, 29.5]
Uric acid (mg/dL) 5.9 [5.2, 6.2] 6.8 [5.7, 9.2] 7.1 [5.6, 9.4]
GFR mL/min/1.73 m2 48.5 [37.8, 56.2] 60.0 [48.0, 79] 57.0 [43.0, 63.0]
Triglycerides (mg/dL) 76.5 [62.7, 187] 136.5 [87.5, 209.7] 112.0 [73.0, 218.3]
Cholesterol (mg/dL) 151.0 [111.0, 218.0] 156.0 [116.0, 195.0] 174.0 [135.0, 204.7]
Hypertension, n(%) 1(25) 2(18) 8(23)
Diabetes, n(%) 0(0) 2(18) 4(13)
Total rejection score 0.34 [0.24, 0.47] 0.23 [0.0, 0.5] 0.20 [0.0, 0.4]
Any rejection score 0.31 [0.18, 0.47] 0.23 [0.0, 0.5] 0.20 [0.0, 0.4]
Peak DSA (MFI) 1278 [482, 2051] 804 [530, 2221] 0 [0, 0]
Positive flow cytometric crossmatch n(%)|| 0(0)* 6(60)* 0(0)
CCB, n(%) 1(25) 3(27) 9(27)
Statin n(%) 2(50) 8(72) 24(71)
Aspirin, n(%) 1(25) 5(45) 8(23)
SRL vs CNI n(%) SRL 3(75); CNI 1(25) SRL 8(72); CNI 3(28) SRL 14(42); CNI 20(58)
MMF vs AZA, n(%) MMF 3(75); AZA 1(25) MMF 9(82); AZA 2(18) MMF 24(71); AZA 10(29)
Prednisone, n(%) 3(75) 8(72) 17(50)
*

P<0.05, DSA I+ vs. DSA II+; + P<0.05, DSA I+ vs. DSA−.;

P<0.05, DSA II+ vs. DSA−

||

Assessed in 17 DSA−, 3 DSAI+ and 10 DSA II+ patients.